• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Animal Vaccines Market

    ID: MRFR/Pharma/47431-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Animal Vaccines Market Research Report By Technology (Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, DNA Vaccines, mRNA Vaccines), By Animal Type (Pets, Livestock, Poultry, Wildlife, Aquaculture), By Route of Administration (Injectable, Oral, Intranasal, Topical) and By Distribution Channel (Veterinary Clinics, Retail Pharmacies, Online Pharmacies, Animal Hospitals)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Animal Vaccines Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    UK Animal Vaccines Market Summary

    The United Kingdom UK Animal Vaccines market is projected to grow significantly over the next decade.

    Key Market Trends & Highlights

    UK Animal Vaccines Key Trends and Highlights

    • The market is valued at 250 USD Million in 2024 and is expected to reach 450 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 5.49% is anticipated from 2025 to 2035.
    • The increasing focus on animal health and welfare is driving market expansion.
    • Growing adoption of advanced vaccination technologies due to rising awareness of zoonotic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 250 (USD Million)
    2035 Market Size 450 (USD Million)
    CAGR (2025-2035) 5.49%

    Major Players

    Vetoquinol, Virbac, Neogen Corporation, Zoetis, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim, HIPRAMSD Animal Health, IDEXX Laboratories, Phibro Animal Health, Associated Veterinary Partners, Patterson Companies, Dechra Pharmaceuticals, Ceva Santé Animale

    UK Animal Vaccines Market Trends

    Several notable developments in the UK Animal Vaccines Market indicate changing dynamics in veterinary treatment. Growing knowledge among pet owners and livestock producers about the need for vaccination in disease prevention is one major market driver. This knowledge has driven more demand for animal vaccinations, which has inspired producers to improve their product lines and create new ideas. Moreover, the UK government's dedication to animal welfare and health, expressed via programs, including the Animal Health and Welfare Pathway, has motivated funding for vaccination research and development, hence promoting market expansion.

    Vaccine development has lately been trending toward more focused treatments and the use of biopharmaceuticals. This indicates a more general movement toward individualized treatment, especially in veterinary settings. The emergence of zoonotic illnesses, especially in the aftermath of worldwide health crises, has also drawn attention to vaccinations safeguarding both people and animals. This offers a notable chance for businesses to create thorough vaccination plans tackling these issues. Furthermore, the use of sophisticated technology in vaccine manufacturing and distribution is increasing. Innovations like DNA vaccines and microencapsulation are gaining popularity, providing better effectiveness and safety.

    The UK’s robust regulatory system guarantees that new vaccinations satisfy rigorous safety and effectiveness criteria before entering the market, hence supporting this trend. The focus on sustainable practices and ecologically friendly solutions is clearly clear as the industry changes to meet new obstacles. Veterinarians are looking increasingly for vaccinations that fit ethical and environmental criteria. Reflecting the evolving scene of animal health care, the UK Animal Vaccines Market is set for expansion propelled by these trends and prospects.

    Market Segment Insights

    Animal Vaccines Market Technology Insights

    The UK Animal Vaccines Market, particularly in the Technology segment, demonstrates a dynamic landscape characterized by various innovative approaches to combat animal diseases. This sector has seen significant advancements, especially with inactivated vaccines, which play a crucial role in providing immunity without causing disease, thereby ensuring animal health and welfare across the UK. Attenuated vaccines are known for their efficacy as they use live, weakened forms of pathogens, offering robust immune responses, which is crucial for livestock boosting production and ensuring food security.

    Moreover, subunit vaccines are gaining traction due to their specificity; these vaccines include only the essential antigens from pathogens, minimizing the risk of adverse reactions and making them safer for animal use.

    The emergence of DNA vaccines and mRNA vaccines indicates a significant shift towards modern biotechnological applications. DNA vaccines introduce genetic material encoding antigens, prompting an immune response without the risks associated with traditional vaccine methods. Meanwhile, mRNA vaccines are at the forefront of cutting-edge research, demonstrating an ability to rapidly adapt to emerging pathogens, which is vital given the increasing incidence of zoonotic diseases. This diversification within the Technology segment of the UK Animal Vaccines Market statistics reflects growing consumer demand for safer and more effective vaccination methods for pets and livestock.

    With changing regulations and an increasing focus on animal welfare, there is a clear trend towards more advanced vaccine technologies. The focus on innovation aligns with the UK government's commitment to enhancing animal health through scientific research. Additionally, as animal diseases evolve, the continual investment in Research and Development is essential to keep pace with these changes, fostering opportunities for growth within this segment.

    The overall upward trajectory indicates a thriving industry, driven by technological advancements and a heightened awareness of animal health among farmers and pet owners alike. This segment is poised for strong growth, supported by governmental policies promoting animal welfare and disease prevention. As the UK strives to maintain its competitive edge in agriculture and animal husbandry, the Technology segment of the UK Animal Vaccines Market remains a critical component in ensuring animal health and agricultural sustainability.

    Animal Vaccines Market Animal Type Insights

    The UK Animal Vaccines Market shows significant diversification across various animal types, reflecting the distinct healthcare needs of each group. The segment encapsulates Pets, Livestock, Poultry, Wildlife, and Aquaculture, with each category holding unique importance within the market. Pets, representing a substantial portion of the market, highlight the growing trend of pet ownership and the increasing awareness among owners regarding vaccination for disease prevention. Livestock remains critical due to the UK's robust agricultural industry, where vaccinations play a pivotal role in maintaining herd health, productivity, and food safety.

    The Poultry segment is particularly important as it deals with common viruses that can greatly affect poultry farming output. Wildlife vaccination initiatives are increasingly recognized for their role in disease management and conservation, addressing both health and ecological concerns. Meanwhile, Aquaculture is gaining traction as the demand for seafood rises, leading to a focus on developing vaccines for aquatic species to combat illnesses. Overall, this market segmentation underscores the varied demands for veterinary vaccines, influenced by factors such as animal population dynamics, disease prevalence, and consumer awareness in the UK.

    Animal Vaccines Market Route of Administration Insights

    The Route of Administration segment plays a crucial role in the UK Animal Vaccines Market, as it directly influences the effectiveness and acceptance of vaccines among various animal populations. Injectable vaccines are often preferred due to their rapid absorption and long-lasting immunity they provide, making them a significant choice for veterinarians. Oral vaccines offer a non-invasive alternative, enhancing compliance among animals that may resist injections, particularly in farm settings. Intranasal vaccines are gaining traction as they facilitate an immune response directly at the entry point of viruses, proving beneficial in respiratory infections.

    Topical vaccines, while less common, provide targeted delivery and ease of administration, especially for large animals. The diverse routes reflect the varied needs within veterinary care, optimizing immunization strategies for different species and health conditions. Growth in the livestock and pet care industries, combined with increasing awareness about animal health, is driving interest in developing innovative vaccination methods in the UK Animal Vaccines Market, ultimately improving overall animal welfare and health outcomes.

    Animal Vaccines Market Distribution Channel Insights

    The UK Animal Vaccines Market's Distribution Channel plays a crucial role in ensuring the availability and accessibility of vaccines for various animal species. Veterinary Clinics are a prominent channel, providing essential services that include consultancy and administration of vaccines, thereby fostering a direct relationship between veterinarians and pet owners. Retail Pharmacies also contribute significantly, serving as convenient access points for non-prescription vaccines and pet care products. Online Pharmacies increasingly dominate, reflecting a larger trend towards digital shopping; they offer ease of access and often competitive pricing, appealing to tech-savvy consumers seeking convenience.

    Furthermore, Animal Hospitals serve as specialized centers, equipped to handle complex cases and ensure comprehensive care, which enhances their importance in the vaccination process. These distribution channels not only facilitate the effective delivery of vaccines but also help address public health concerns by managing animal health trends, contributing to a significant increase in the UK Animal Vaccines Market revenue. The growing pet population and rising awareness about zoonotic diseases further drive demand, presenting opportunities for growth within these channels.

    Each of these avenues presents unique advantages that cater to the diverse needs of pet owners, which is essential for the continued evolution of the UK Animal Vaccines Market industry.

    Get more detailed insights about UK Animal Vaccines Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    The UK Animal Vaccines Market is characterized by a dynamic competitive environment that encompasses various factors influencing market performance, including innovation, regulatory landscape, and shifting consumer preferences towards animal health. This market serves a broad array of animal species, including pets, livestock, and aquaculture species, all of which require effective vaccination solutions to prevent diseases and ensure overall health. Companies operating within this space face the constant challenge of adapting to advancements in biotechnology and addressing the growing concerns around animal welfare.

    As the market continues to evolve, firms are exploring strategic partnerships, mergers, and acquisitions to enhance their product portfolios and gain competitive advantages.

    Vetoquinol stands out in the UK Animal Vaccines Market thanks to its strong commitment to research and development, which continuously strengthens its position in the sector. The company is recognized for providing a wide range of veterinary products, including vaccines that address prevalent diseases in both companion and production animals. Vetoquinol's emphasis on high-quality formulations and effective vaccine administration has garnered trust from veterinary professionals across the UK. The company thrives on robust distribution networks and solid customer relationships, enabling it to maintain a significant market presence.

    Additionally, its focus on adopting innovative technologies in vaccine development has ensured that Vetoquinol remains at the forefront of the animal health industry.

    Virbac is another key player in the UK Animal Vaccines Market, known for its comprehensive portfolio of veterinary vaccines that span various animal species, particularly dogs, cats, and livestock. The company's notable commitment to combating infectious diseases and promoting animal health is evident in its range of award-winning products. Virbac has consistently reinforced its market presence through a series of strategic partnerships and acquisitions, allowing for an expansion of its product offerings in the UK.

    Its strengths lie in its advanced research capabilities, which support the development of effective vaccines and medication tailored for the specific needs of the UK market. With a reputation for reliability and efficacy, Virbac’s focus on quality has fostered strong loyalty among practitioners in the veterinary field, ultimately contributing to its growth and sustainability in the competitive landscape of animal vaccines in the UK.

    Key Companies in the UK Animal Vaccines Market market include

    Industry Developments

    Recent developments in the UK Animal Vaccines Market have been characterized by increased focus on innovation and strategic partnerships among major players. Companies such as Vetoquinol, Virbac, and Zoetis have been investing in Research and Development to enhance their vaccine offerings amidst rising demand due to animal health concerns. In terms of market dynamics, the overall valuation of the animal vaccines market in the UK has seen significant growth, partly driven by the increasing livestock population and the urgent need for effective disease control measures, particularly following outbreaks of various animal diseases in recent years.

    In June 2023, Merck Animal Health announced the acquisition of a portfolio of vaccine products from a smaller company, which aims to strengthen its position in the UK market. Additionally, in October 2022, Elanco Animal Health expanded its range through an acquisition targeting a niche vaccine category. Moreover, recent regulatory changes in the UK are likely to impact the approval processes for veterinary pharmaceuticals, thus influencing market entry strategies for companies like Boehringer Ingelheim and Neogen Corporation.

    The focus on sustainability and efficiency in manufacturing processes is also a rising trend in the market as stakeholders prepare for evolving consumer demands.

    Market Segmentation

    Animal Vaccines Market Technology Outlook

    • Inactivated Vaccines
    • Attenuated Vaccines
    • Subunit Vaccines
    • DNA Vaccines
    • mRNA Vaccines

    Animal Vaccines Market Animal Type Outlook

    • Pets
    • Livestock
    • Poultry
    • Wildlife
    • Aquaculture

    Animal Vaccines Market Distribution Channel Outlook

    • Veterinary Clinics
    • Retail Pharmacies
    • Online Pharmacies
    • Animal Hospitals

    Animal Vaccines Market Route of Administration Outlook

    • Injectable
    • Oral
    • Intranasal
    • Topical

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 223.12(USD Million)
    MARKET SIZE 2024 250.0(USD Million)
    MARKET SIZE 2035 450.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.489% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Vetoquinol, Virbac, Neogen Corporation, Zoetis, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim, HIPRA, MSD Animal Health, IDEXX Laboratories, Phibro Animal Health, Associated Veterinary Partners, Patterson Companies, Dechra Pharmaceuticals, Ceva Santé Animale
    SEGMENTS COVERED Technology, Animal Type, Route of Administration, Distribution Channel
    KEY MARKET OPPORTUNITIES Increasing demand for livestock health, Growth in companion animal ownership, Advancements in vaccine technology, Rising awareness of zoonotic diseases, Government support for vaccination programs
    KEY MARKET DYNAMICS Rising pet ownership, Increasing zoonotic diseases, Regulatory advancements, Innovative vaccine technologies, Growing demand for livestock health
    COUNTRIES COVERED UK

    FAQs

    What is the projected market size of the UK Animal Vaccines Market by 2035?

    The UK Animal Vaccines Market is expected to be valued at 450.0 USD Million by the year 2035.

    What is the expected compound annual growth rate (CAGR) for the UK Animal Vaccines Market from 2025 to 2035?

    The market is projected to grow at a CAGR of 5.489 percent from 2025 to 2035.

    Which technology segment is anticipated to have the largest market share in 2035?

    Inactivated Vaccines are expected to dominate the market with a value of 170.0 USD Million in 2035.

    What is the market value of Attenuated Vaccines in the UK Animal Vaccines Market for 2024?

    Attenuated Vaccines are valued at 70.0 USD Million in the year 2024.

    Who are the key players in the UK Animal Vaccines Market?

    Major players include Vetoquinol, Zoetis, Merck Animal Health, and Boehringer Ingelheim.

    What are the market projections for mRNA Vaccines by 2035?

    mRNA Vaccines are anticipated to reach a market value of 60.0 USD Million by the year 2035.

    How much is the market for Subunit Vaccines expected to grow from 2024 to 2035?

    The market for Subunit Vaccines is projected to increase from 30.0 USD Million in 2024 to 50.0 USD Million in 2035.

    What is the estimated market size for DNA Vaccines in the UK Animal Vaccines Market in 2024?

    The estimated market size for DNA Vaccines is 25.0 USD Million in the year 2024.

    What growth trends are influencing the UK Animal Vaccines Market?

    Growing awareness of animal health and advancements in vaccine technology are key growth drivers.

    What challenges are currently faced in the UK Animal Vaccines Market?

    Regulatory hurdles and competition among major players present significant challenges in the market.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials